
Article 1 
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Article 2 
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 10 March 2015.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘tulathromycin’ is replaced by the following:

Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic classification
‘Tulathromycin (2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2-ethyl-3,4,10,13-tetra-hydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethy-lamino)-ß-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalents Ovine, caprine 450 μg/kg Muscle Not for use in animals from which milk is produced for human consumption Anti-infectious agents/Antibiotics’
250 μg/kg Fat
5 400 μg/kg Liver
1 800 μg/kg Kidney
Bovine 300 μg/kg Muscle
200 μg/kg Fat
4 500 μg/kg Liver
3 000 μg/kg Kidney
Porcine 800 μg/kg Muscle
300 μg/kg Skin and fat in natural proportions
4 000 μg/kg Liver
8 000 μg/kg Kidney
